DESANTIS CARL 4

What Happened
Carl DeSantis, a reported 10% owner of Integrated Biopharma, reported gifts of company common stock on 2026-03-24. He disposed of 1,356,293 shares and 7,392 shares as gifts (total 1,363,685 shares) at $0.00 per share (no cash proceeds). The transfers were reported to have been made to CDDS 2.0, LLC, a Florida LLC controlled by Damon DeSantis.

Key Details

• Transaction date(s): March 24, 2026; Form 4 filed March 26, 2026. Filing appears timely.
• Shares transferred: 1,356,293 shares (footnote F1) and 7,392 shares (footnote F3); total 1,363,685 shares; price $0.00; total value $0.
• Reported holdings after the transfers (per footnote F4): 9,116,547 shares held by CD Financial, LLC; 2,235,417 shares in the Carl DeSantis Revocable Trust; and 14,709 shares in the Estate of Carl DeSantis — total 11,366,673 shares.
• Notable footnotes: F1/F3 describe the specific entity-to-entity transfers to CDDS 2.0, LLC; F2/F4 show holdings figures used in the filing.

Context

• These were gifts, not open-market sales or purchases; gifts generally do not signal a trading view of the stock.
• As a 10% owner, these transfers are large ownership-structure moves between related entities rather than routine insider buy/sell disclosures by an executive.
• No derivative exercises, 10b5-1 plan, or tax-withholding codes were indicated in the transaction entries.